Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fossa

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dogA A Fossa, M J DePasquale, J Morrone, et al.
Clinical Pharmacology and Therapeutics|August 5, 2011
The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafilA A Fossa, G Langdon, J-P Couderc, et al.
Journal of Cardiovascular Pharmacology|July 1, 1992
Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captoprilA A Fossa, L J Weinberg, R L Barber, et al.
Toxicology and Applied Pharmacology|September 25, 2012
Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetineAnthony A Fossa, Todd A Wisialowski, Thomas Cremers, et al.
American Heart Journal|June 20, 2012
Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effectsChristine E Garnett, Hao Zhu, Marek Malik, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|November 1, 2007
Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalolAnthony A Fossa, Todd Wisialowski, Kimberly Crimin, et al.
Cardiovascular Drug Reviews|February 22, 2003
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1)W Ross Tracey, Mary C Allen, Donald E Frazier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|December 17, 2016
Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by ChlamydiaM A F Queiroz, S T M Gomes, N C C Almeida, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dogA A Fossa, M J DePasquale, J Morrone, et al.
Clinical Pharmacology and Therapeutics|August 5, 2011
The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafilA A Fossa, G Langdon, J-P Couderc, et al.
Journal of Cardiovascular Pharmacology|July 1, 1992
Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captoprilA A Fossa, L J Weinberg, R L Barber, et al.
Toxicology and Applied Pharmacology|September 25, 2012
Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetineAnthony A Fossa, Todd A Wisialowski, Thomas Cremers, et al.
American Heart Journal|June 20, 2012
Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effectsChristine E Garnett, Hao Zhu, Marek Malik, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|November 1, 2007
Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalolAnthony A Fossa, Todd Wisialowski, Kimberly Crimin, et al.
Cardiovascular Drug Reviews|February 22, 2003
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1)W Ross Tracey, Mary C Allen, Donald E Frazier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|December 17, 2016
Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by ChlamydiaM A F Queiroz, S T M Gomes, N C C Almeida, et al.
Pageof 4